Cost-effectiveness of primary care-based risk assessment and hereditary cancer genetic testing

Abstract Background Guidelines recommend identifying individuals with a family or personal history of cancer, offering genetic testing, with the goal of managing disease risk. Yet, risk assessment (“screening”) and genetic testing remain underutilized in the primary care setting and the value of an...

Descripció completa

Dades bibliogràfiques

Autors principals:	Beth Devine, Sanne E. Aalbers, HuiHsuan Chan, Shangqing Jiang, Emerson J. Dusic, Sarah Knerr, Heather M. Harris, Catharine Wang, Barbara M. Norquist, Laurie A. Riemann, Jeannine M. Brant, Brian H. Shirts, Elizabeth M. Swisher
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-12-01
Col·lecció:	BMC Primary Care
Matèries:	Pragmatic clinical trial Hereditary cancer risk assessment/Screening Genetic testing Primary care Cost-effectiveness Decision modeling
Accés en línia:	https://doi.org/10.1186/s12875-025-03137-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!